The Effect of Food on the Oral Bioavailability of Drugs: a Review of Current Developments and Pharmaceutical Technologies for Pharmacokinetic Control

• Yu LX . Straughn AB, Faustino PJ. The effect of food on the relative bioavailability of rapidly dissolving immediate-release solid oral products containing highly soluble drugs. Mol. Pharm.1, 357–362 (2004).
   PubMed Web of Science ®Google Scholar
• Schmidt LE , DalhoffK. Food-drug interactions. Drugs62, 1481–1502 (2002).
   PubMed Web of Science ®Google Scholar
• Lentz KA . Current methods for predicting human food effect. AAPS J.10, 282–288 (2008).
   PubMed Web of Science ®Google Scholar
• Gamsiz ED , AshtikarM, CrisonJ, WaltoszW, BolgerMB. Carrier RL. Predicting the effect of fed-state intestinal contents on drug dissolution. Pharm. Res.27, 2646–2656 (2010).
   PubMed Web of Science ®Google Scholar
• Welling PG . Effect of food on drug absorption. Annu. Rev. Nutr.16, 383–415 (1996).
   PubMed Web of Science ®Google Scholar
• Singh BN . Effect of food on clinical Pharmacokinetics. Clin. Pharmacokinet.37, 213–255 (1999).
   PubMed Web of Science ®Google Scholar
• Adithan C . Food & drug bioavailability. Indian J. Med. Res.121, 631–633 (2005).
   PubMed Web of Science ®Google Scholar
• Deferme S , AugustijnsP. The effect of food components on the absorption of P-gp substrates; a review. J. Pharm. Pharmacol.55, 153–162 (2003).
   PubMed Web of Science ®Google Scholar
• Amidon GL , LennernasH, ShahVP, CrisonJR. A theoretical basis for a biopharmaceutical drug classification: the correlation of in vitro drug product dissolution and in vivo bioavailability. Pharm. Res,12, 413–420 (1995).
   PubMed Web of Science ®Google Scholar
• Lobenberg R , AmidonGL. Modern bioavailability, bioequivalence and biopharmaceutics classification system. New scientific approaches to international regulatory standards. Eur. J. Pharm. Biopharm.50, 3–12 (2000).
   PubMed Web of Science ®Google Scholar
• Lipinski CA , LombardoF, DominyBW, FeeneyPJ. Poor aqueous solubility – an industry wide problem in drug discovery. Am. Pharm. Rev.5, 82–85 (2002).
   Google Scholar
• Merisko-Liversidge E , LiversidgeGG, CooperER. Nanosizing: a formulation approach for poorly-water-soluble compounds. Eur. J. Pharm. Sci.18, 113–120 (2003).
   PubMed Web of Science ®Google Scholar
• Yasuji T , HaslamJ, KajiyamaA, McIntoshiMP, RajewskiRA. Preliminary evaluation of polymer-based drug composite production by coacervate desolvation with supercritical carbon dioxide. J. Pharm. Sci.95, 581–588 (2006).
   PubMed Web of Science ®Google Scholar
• Zia V , RajewskiRA, StellaVJ. Effect of cyclodextrin charge on complexation of neutral and charged substrates; comparison of (SBE)-7M-β-CD to HP-β-CD. Pharm. Res.18, 667–673 (2001).
   PubMed Web of Science ®Google Scholar
• Yang S , GursoyRN, LambertG, BenitaS. Enhanced oral absorption of Paclitaxel in a novel self-microemulsifying drug delivery system with or without concomitant use of p-glycoprotein inhibitors. Pharm. Res.21, 261–270 (2004).
   PubMed Web of Science ®Google Scholar
• Wu CW , BenetLZ. Predicting drug deposition via application of BCS: transport/absorption/elimination interplay and development of a biophamaceutics drug disposition classification system. Pharm. Res.22, 11–23 (2005).
   PubMed Web of Science ®Google Scholar
• Smide JH , OffringaJC, CrommelinDJ. Dissolution kinetics of griseofulvin in sodium dodecylsulphate solutions. J. Pharm. Sci.76, 711–714 (1987).
   PubMed Web of Science ®Google Scholar
• Kassem MA , MatthaAG, El-NimrAEM. Study of the influence of sodium taurocholate (STC) and sodium glycocholate (SGC) on the mass transfer of certain drugs. Digoxin. Int. J. Pharm.12, 1–9 (1982).
   Google Scholar
• Yano K , MasaokaY, KataokaM, SakumaS, YamashitaS. Mechanisms of membrane transport of poorly soluble drugs: role of micelles in oral absorption processes. J. Pharm. Sci.99, 1336–1345 (2010).
   PubMed Web of Science ®Google Scholar
• Sugano K . Computational oral absorption simulation for low-solubility compounds. Chem. Biodivers.6, 2014–2029 (2009).
   PubMed Web of Science ®Google Scholar
• Custodio JM , WuCY, BenetLZ. Predicting drug disposition, absorption/elimination/transporter interplay and the role of food on drug absorption. Adv. Drug Deliv. Rev.60, 717–733 (2008).
   PubMed Web of Science ®Google Scholar
• Marasanapalle VP , CrisonJR, MaJ. Investigation of some factors contributing to negative food effects. Biopharm Drug Dispos.30, 71–80 (2009).
   PubMed Web of Science ®Google Scholar
• Marasanapalle VP , CrisonJR, DevarakondaKRet al. Predictive models for drugs exhibiting negative food effects based on their biopharmaceutical characteristics. Drug Develop Ind Pharm. 37, 1–10 (2011).
   PubMed Web of Science ®Google Scholar
• Bruesewitz C , FunkeA, KuhlandUet al. Comparison of permeation enhancing strategies for an oral factor Xa inhibitor using the Caco-2 cell monolayer model. Eur J. Pharm. Biopharm 64, 230–237 (2006).
   Web of Science ®Google Scholar
• Dahan A , AmidonGL. Segmental dependent transport of low permeability compounds along the small intestine due to p-glycoprotein: the role of efflux transport in the oral absorption of BCS Class III drugs. Molecular Pharmaceutics6, 10–28 (2008).
   Google Scholar
• Kawai Y , FujiiY, TabataFet al. Profiling and trend analysis of food effects on oral drug absorption considering micelle interaction and solubilization by bile micelles. Drug Metab. Pharmacokinet. 26, 180–191 (2011).
   PubMed Web of Science ®Google Scholar
• Deferme S , AugustijnsP. The effect of food components on the absorption of P-gp substrates: a review. J. Pharm. Pharmacol.55, 153–162 (2003).
   PubMed Web of Science ®Google Scholar
• Shirasaka Y , SuzukiK, NakanishiT, TamaiI. Differential effect of grapefruit juice on intestinal absorption of statins due to inhibition of organic anion transporting polypeptide and/or P-glycoprotein. J. Pharm. Sci.100, 3843–3853 (2011).
   PubMed Web of Science ®Google Scholar
• Bailey DG , SpenceJD, EdgerB. Ethanol enhances the hemodynamic effects of felodipine. Clin. Invest. Med.12, 357–362 (1989).
   PubMed Web of Science ®Google Scholar
• Harley MJ , CancalonP, WindmerWW. The effect of grapefruit juice on drug diposition. Expert Opin. Drug Metab. Taxicol.7, 267–286 (2011).
   PubMed Web of Science ®Google Scholar
• Stewart CC , StrotherA. Glucose consumption by rates decreases cytochrome P450 enzyme activity by altering hepatic lipid. Life Sci.64, 2163–2172 (1999).
   PubMed Web of Science ®Google Scholar
• Koumaravelou K , AdithanC, ShashindranCH, AsadM, AbrahamBK. Influence of honey on orally and intravenously administered diltiazem kinetics in rabbits. Indian J. Exp. Boil.40, 1164–1168 (2002).
   PubMedGoogle Scholar
• Koumaravelou K , AdithanC, ShashindranCH, AsadM, AbrahamBK. Effect of honey on carbamazepine kinetics in rabbits. Indian J. Exp. Boil.40, 560–563 (2002).
   PubMedGoogle Scholar
• Sukrit SKG . Influence of honey on the pharmacokinetics of phenitoin in healthy rabbits. Methods FInd Exp. Clin. Pharmacol.25, 367–370 (2003).
   PubMedGoogle Scholar
• Jaganathan SK . Can flavonoids from honey alter multidrug resistance? Med. Hypotheses76, 535–537 (2011).
   PubMed Web of Science ®Google Scholar
• Han HK . The effects of black pepper on the intestinal absorption and hepatic metabolism of drugs. Expert Opin. Drug Metab. Toxicol.7, 721–729 (2011).
   PubMed Web of Science ®Google Scholar
• Won CS , OberliesNH, PaineMF. Influence of dietary substances on intestinal drug metabolism and transport. Cancer Chemother. Pharmacol.11, 778–792 (2010).
   Google Scholar
• Dressman JB , AmidonGL, ReppasC. Dissolution testing as a prognostic tool for oral drug absorption: immediate release dosage forms, Pharm. Res.15, 11–22 (1998).
   PubMed Web of Science ®Google Scholar
• Nicolaides E , SymillidesM, DressmanJB, ReppasC. Biorelevant dissolution testing to predict the plasma profile of lipophilic drugs after oral administration. Pharm. Res.18, 380–388 (2001).
   PubMed Web of Science ®Google Scholar
• Jantratid E , JanssenN, ReppasC, DressmanJB. Dissolution media simulating conditions in the proximal human GI tract: an update. Pharm. Res.25, 1663–1676 (2008).
   PubMed Web of Science ®Google Scholar
• Sreenivasulu K , RaghuP. Nair KM. Polyphenol-rich beverages enhance zinc uptake and metallothinein expression in Caco-2 cells. J. Food Sci.75, H123–H128 (2010).
   PubMed Web of Science ®Google Scholar
• Aspenstrom-Fagerlund B , SundstromB, TallkvistJet al. Fatty acids increase paracellular absorption of aluminium across Caco-2 cell monolayers. Chem. Biol. Interact. 181, 272–278 (2009).
   PubMed Web of Science ®Google Scholar
• Deat E , Blanquet-DiotS, JarrigeJFet al. Combining the dynamic TNO-gastrointestinal tract system with a Caco-2 cell culture model: application to the assessment of lycopene and α-tocopherol bioavailability from whole food. J. Agric Food Chem. 57, 11314–11320 (2009).
   PubMed Web of Science ®Google Scholar
• Waldman SA , MorganrothJ. Effects of food on the bioequivalence of differet verapamil sustained-release formulations. J. Clin. Pharmacol.35, 163–169 (1995).
   PubMed Web of Science ®Google Scholar
• Buice RG , SubramanianVG, LaneE. Bioequivalence of highly variable drug: an experience with nadolol. Pharm. Res.13, 1109–1115 (1996).
   PubMed Web of Science ®Google Scholar
• Hosney EA , El-SayedYM, Al-MeshalMA. Effect of food on bioavailability of bioadhesive-containing indometachin tablet in dogs. Int. J. Pharm.112, 87–91 (1994).
   Google Scholar
• Wu Y , LoperA, LandisEet al. The role of biopharmaceutics in the development of a clinical nanoparticles formulation of MK-0869: a beagle dog model predicts improved bioavailability and diminished food effect on absorption in human. Int. J. Pharm. 285, 135–146 (2004).
   PubMed Web of Science ®Google Scholar
• Woo JS , SongYK, HongJY, LimSJ, KimSK. Reduced food effect and enhanced bioavailability of a self-microemulsifying formulation of itraconazole in healthy volunteers. Eur. J. Pharm. Sci.33, 159–165 (2008).
   PubMed Web of Science ®Google Scholar
• Charman WN , RoggeMC, BoddyAW, BergerBM. Effect of food and a monoglyceride emulsion formulation on danazol bioavailability. J. Clin. Pharmacol.33, 381–386 (1993).
   PubMed Web of Science ®Google Scholar
• Grove M , MüllertzA, PedersenGP, NielsenJL. Bioavailability of seocalcitol III. administration of lipid-based formulations to minipigs in the fasted and fed state. Eur. J. Pharm. Sci.31, 8–15 (2007).
   PubMed Web of Science ®Google Scholar
• Perlman ME , MurdandeSB, GumkowskiMJet al. Development of a selfemulsifying formulation that reduces the food effect for torceptrapid. Int. J. Pharm. 351, 15–22 (2008).
   PubMed Web of Science ®Google Scholar
• Thombre G , HerbigSM, AldermanJA. Improved ziprasidone formulations with enhanced bioavailability in fasted state and reduce food effect Pharm. Res. doi:10.1007/s11095–011–0505–0507 (2011).
   PubMedGoogle Scholar
• Klein CE , ChiuYL, AwniWet al. The tablet formulation of lopinavir/ritonavir provides similar bioavailability to the soft-gelatin capsule formulation with less pharmacokinetic variability and diminished food effect. J. Acquir. Immyne. Defic. Sybdr. 44, 401–410 (2007).
   PubMed Web of Science ®Google Scholar
• Auiler JF , LuK, LynchJM, GelotteCK. Effect of food on early drug exposure from extended-release stimulants: results from the Concerta, Adderall XR Food Evaluation (CAFE) Study. Curr. Med. Res. Opin.18, 311–316 (2002).
   PubMed Web of Science ®Google Scholar
• Malaterre V , OgorkaJ, LoggiaN, GurnyR. Oral osmotically driven systems: 30 years of development and clinical use. Eur. J. Pharm. Biopharm.73, 311–323 (2009).
   PubMed Web of Science ®Google Scholar
• Lyseng-Williamson KA , JarvisB, WagstaffAJ. Tamsulosin. an update of its role in the management of lower urinary tract symptoms. Drugs62, 135–167 (2002).
   PubMed Web of Science ®Google Scholar
• Michel MC , KorstanjeC, KrauwinkelWet al. The pharmacokinetic profile of Tamsulosin Oral Controlled Absorption System (OCAS®). Euro. Urol. Suppl. 4, 15–24 (2005).
   Web of Science ®Google Scholar
• Sako K , NakashimaH, SawadaT, FukuiM. Relationship between gelation rate of controlled-release acetaminophen tablets containing polyethylene oxide and colonic drug release in dogs. Pharm. Res.13, 594–598 (1996).
   PubMed Web of Science ®Google Scholar
• Tanno FK , SakumaS, MasaokaYet al. Site-specific drug delivery to the middle-to-lower region of the small intestine reduces food-drug interactions that are responsible for low drug absorption in the fed state. J. Pharm. Sci. 97, 5341–5353 (2008).
   PubMed Web of Science ®Google Scholar
• Mano Y , UsuiT, KamimuraH. Hepatobiliary taransport of YM466, a novel factor Xa inhibitor, in rats. Eur. J. Drug Metab. Pharmacokinet.31, 117–121 (2006).
   PubMed Web of Science ®Google Scholar
• Katsuma M , WatanabeS, KawaiH, TakemuraS, MasudaY, FukuiM. Studies on lactulose formulation for colon-specific drug delivery. Int. J. Pharm.249, 33–43 (2002).
   PubMed Web of Science ®Google Scholar
• Katsuma M , WatanabeS, TakemuraS. Scitigraphic evaluation of a novel colon-targeted delivery system (CODES™) in healthy volunteers. J. Pharm. Sci.93, 1287–1299 (2004).
   PubMed Web of Science ®Google Scholar

Websites

• The United States Pharmacopeia-The National Formulary USP 34/NF29. www.usp.org/products/USPNF/
   Google Scholar
• US Department of Health and Human Servise, US FDA, CDER. Food effect bioavailability and fed bioequibalence. www.fda.gov/downloads/regulatoryinformation/guidances/ucm126833.pdf
   Google Scholar
• European Medicines Agency, Guideline of the investigation of bioequivalence. www.emea.europa.eu/docs/en_GB/document_library/Scientific_guideline/2010/01/WC500070039.pdf
   Google Scholar
• National Institute of Healthy Science, Japan, Guideline for bioequivalence studies of generic products. www.nihs.go.jp/drug/be-guide(e)/Generic/be97E.pdf
   Google Scholar